Innoviva Seeks Shareholder Approval for New 2026 Equity Incentive Plan with 10% Potential Dilution

summarizeSummary

Innoviva, Inc. filed its definitive proxy statement, seeking shareholder approval for a new 2026 Equity Incentive Plan that could result in approximately 10% dilution, alongside other routine proposals.

check_boxKey Events

• Shareholder Meeting Scheduled

  The Annual Meeting of Stockholders is scheduled for May 4, 2026, where shareholders will vote on several key proposals.

• New Equity Incentive Plan Proposed

  Shareholders are asked to approve the 2026 Equity Incentive Plan, reserving 9,000,000 additional shares of common stock, representing approximately 10% potential dilution on a fully diluted basis.

• Significant Contingent Equity Grants

  Upon approval of the 2026 Plan, 875,077 stock options and 508,676 restricted stock units (RSUs) will be immediately granted to executive officers and other employees, including 312,500 options and 126,646 RSUs for the CEO.

• Routine Governance Proposals

  Other proposals include the election of five directors, a non-binding advisory vote on executive compensation, and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm.

auto_awesomeAnalysis

Innoviva, Inc. has filed its definitive proxy statement (DEF 14A) for its upcoming Annual Meeting on May 4, 2026. The most significant proposal is the approval of the 2026 Equity Incentive Plan, which would reserve an additional 9,000,000 shares of common stock for issuance. This represents approximately 10% potential dilution on a fully diluted basis. Upon approval, contingent awards of 875,077 stock options and 508,676 restricted stock units (RSUs) are slated for immediate grant to executive officers and other employees, including substantial awards to the CEO, CFO, and CAO. While this level of potential dilution is notable, the company emphasizes the plan's importance for attracting, retaining, and motivating key talent, aligning their interests with long-term shareholder value. The plan also incorporates several good governance features, such as prohibitions on repricing awards without shareholder approval, a clawback policy, and limits on non-employee director awards. This proposal comes after the company reported strong 2025 financial results and initiated a $125 million share repurchase program on February 25, 2026, providing a positive context for this capital allocation decision.